Publication:
Entecavir Treatment of Chronic Hepatitis D

No Thumbnail Available
Date
2012-09-01T00:00:00Z
Authors
Kabacam, Gokhan
ÖNDER, Fatih Oğuz
Yakut, Mustafa
Seven, GÜLSEREN
Karatayli, Senem C.
Karatayli, Ersin
Savas, Berna
Idilman, Ramazan
Bozdayi, A. Mithat
Yurdaydin, Cihan
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Background. Hepatitis D virus (HDV) requires hepatitis B surface antigen (HBsAg) to propagate infection and cause disease. Entecavir is a nucleoside analog with potent antiviral efficacy, and in the woodchuck animal model it also decreased hepatitis B virus (HBV) cccDNA and woodchuck surface antigen. The aim of this study was to investigate the efficacy of entecavir in chronic hepatitis D (CHD).
Description
Keywords
Citation
Kabacam G., ÖNDER F. O. , Yakut M., Seven G., Karatayli S. C. , Karatayli E., Savas B., Idilman R., Bozdayi A. M. , Yurdaydin C., -Entecavir Treatment of Chronic Hepatitis D-, CLINICAL INFECTIOUS DISEASES, cilt.55, ss.645-650, 2012
Collections
Page Views

0

File Downloads

0

Sustainable Development Goals